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Early-stage cancer and its interactions with the immune
system are still not fully understood. In order to better
understand these processes, researchers employ different
methods. Simulation and in particular, agent-based simu-
lation (ABS) have been found useful tools for understand-
ing it (Look et al., 1981; Castiglione et al., 1999, 2001;
Bonabeau, 2002; Figueredo and Aickelin, 2011; Figueredo
et al., 2013a,b).
In a previous study (Figueredo et al., 2013b) we have built
an ABS model to study the interplay of immune cells and
early-stage cancer. The model considers interactions be-
tween tumour cells and immune effector cells, as well as
the immune-stimulatory and suppressive cytokines IL-2 and
TGF-β. IL-2 molecules mediate the immune response to-
wards tumour cells. They interfere on the proliferation of
effector cells according to the number of tumour cells in the
system. Conversely, TGF-β stimulates tumour growth and
suppresses the immune responses by inhibiting the activa-
tion of effector cells and reducing tumour-antigen expres-
sion.
In order to validate our model, we used a well-established
mathematical model found in the literature (Arciero et al.,
2004). While at average both models do not show a sta-
tistical significant difference, some additional trends in the
results of the ABSmodel are observed. As ABS is a stochas-
tic simulation method, it was run for multiple times. Instead
of having one solution, as it is the case for a deterministic
mathematical model, ABS produces a variety of outcomes.
These solutions are usually very similar. In our cases study,
however, we could observe some instances which could not
have been observed by using analytical methods (see Fig-
ure 1).
The use of ABS modelling has therefore led to the dis-
covery of additional “rare” patterns, which we would have
not been able to derive by using analytical methods. These
“extreme cases” indicate that there might be circumstances
where the tumour cells are completely eliminated by the
immune system, without the need of any cancer therapies.
We strongly believe that the observed emergent behaviour
produced by stochastic simulation can make a useful con-
tribution to assisting immunological research. With the
additional information supplied from the ABS, immunolo-
gists can test new hypotheses and further investigate whether
these extreme cases actually occur in reality and why.
Currently, we are working on a methodology for defin-
ing experimental conditions that would allow us to observe
similar emergent behaviour in other simulation experiments
related to early-stage cancer research. One important aspect
here is to investigate the statistical conditions under which
emergent behaviour starts to appear. The questions we are
looking at are:
1. Howmany replications of our stochastic simulation do we
have to run before we can expect to see rare behaviours?
2. Is there any regularity in the growth of these rare emerging
patterns?
3. What are the factors that need to be considered when pre-
dicting the occurrences of emerging patterns (e.g. level of
dynamics in the model)?
The patterns obtained in our previous work were a result
of 50 independent runs of the ABS model (Figueredo et al.,
2013b). In order to further advance our knowledge regard-
ing these patterns we are currently running experiments with
10,000 independent runs in order to verify whether there is
any regularity in pattern growth. We also intend to validate
our results with immunologists. It is hoped that the develop-
ment of a methodology to further investigate extreme cases
could assist in defining suitable vaccination strategies and
the appropriateness of cancer treatments by the prediction
of the possible outcome scenarios and how frequently they
take place.
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(a) Simulation results for tumour cells (b) Simulation results for effector cells
Figure 1: Simulation results: the dashed line (red) shows the mathematical output; the lines in black show exemplar ABS results
for 6 runs. As it can be seen, there are some results very close to the mathematical formulation and others presenting more
variability due to the ABS stochastic behaviour. These variations, however, follow the same pathway as the analytical solution.
The dashed-dotted line (blue) shows the rare cases determined by the ABS simulations.
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